Molecular analysis of the hepatitis B virus presurface and surface gene in patients from eastern China with occult hepatitis B

This study was designed to detect and analyze mutations that occur within the presurface and surface (pre‐S/S) gene of HBV in patients with occult hepatitis B, and determine their relationship to that disorder. Among 254 HBsAg negative samples of blood collected in eastern China, 183 were positive for anti‐HBc alone, 61 were positive for anti‐HBe alone, and 10 samples were positive for HBeAg. Within this group, 15 samples were found to be HBV DNA positive by real‐time PCR and were designated Group I. A control group of 28 HBsAg positive samples were chosen at random from patients with chronic hepatitis B and designated Group II. The HBV pre‐S/S gene was amplified by PCR and subjected to sequencing analysis. Occult hepatitis B was found in 1.6% of the patients with anti‐HBc alone and in 3.3% of those with anti‐HBe alone. Occult hepatitis B also was found in all HBsAg negative but HBeAg positive samples. Sequencing analysis showed a significant correlation between point mutations within the “a” determinant and occult hepatitis B (P < 0.0001), and a close relationship between pre‐S deletion mutations and occult hepatitis B (P = 0.06). There were unique amino acid mutations at the G145 position other than G145R. The HBV DNA levels in patients with occult hepatitis B were significantly lower than those found in the control group. The “a” determinant mutations and pre‐S deletions may play important roles in occult hepatitis B by affecting the expression, synthesis and secretion of the S protein and by impeding viral release and replication. J. Med. Virol. 85: 979–986, 2013. © 2013 Wiley Periodicals, Inc.

[1]  S. Yeh,et al.  Influence of mutations in hepatitis B virus surface protein on viral antigenicity and phenotype in occult HBV strains from blood donors. , 2012, Journal of hepatology.

[2]  S. Alavian,et al.  High prevalence of occult hepatitis B virus infection in children born to HBsAg-positive mothers despite prophylaxis with hepatitis B vaccination and HBIG. , 2012, Journal of hepatology.

[3]  S. Sauleda,et al.  T cell responses and viral variability in blood donation candidates with occult hepatitis B infection. , 2012, Journal of hepatology.

[4]  X. Teng,et al.  Viral deletions among healthy young Chinese adults with occult hepatitis B virus infection. , 2012, Virus research.

[5]  Valentina Svicher,et al.  Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detection. , 2012, Antiviral research.

[6]  Roger Y Dodd,et al.  Nucleic acid testing to detect HBV infection in blood donors. , 2011, The New England journal of medicine.

[7]  R. Crowther,et al.  Impact of hepatitis B virus surface protein mutations on the diagnosis of occult hepatitis B virus infection , 2010, Hepatology.

[8]  G. Portella,et al.  Immunocompromised Patients with HBsAg a Determinant Mutants: Comparison of HBsAg Diagnostic Assays , 2010, Intervirology.

[9]  A. Ursitti,et al.  Appearance of HbeAg in an Occult Persistent Hepatitis B Virus Infection , 2010, Intervirology.

[10]  F. Hollinger,et al.  Occult hepatitis B virus infection: a covert operation , 2010, Journal of viral hepatitis.

[11]  A. E. Yeo,et al.  Molecular Characteristics of Occult Hepatitis B Virus from Blood Donors in Southeast China , 2009, Journal of Clinical Microbiology.

[12]  J. Allain,et al.  Diagnostic algorithm for HBV safe transfusion. , 2009, Blood transfusion = Trasfusione del sangue.

[13]  X. Teng,et al.  Molecular characterization and functional analysis of occult hepatitis B virus infection in Chinese patients infected with genotype C , 2009, Journal of medical virology.

[14]  F. Hollinger Hepatitis B virus infection and transfusion medicine: science and the occult , 2008, Transfusion.

[15]  V. Soriano,et al.  Hepatitis B virus escape mutants induced by antiviral therapy. , 2008, The Journal of antimicrobial chemotherapy.

[16]  V. Meli,et al.  Can the serological status of “anti‐HBc alone” be considered a sentinel marker for detection of “occult” HBV infection? , 2008, Journal of medical virology.

[17]  M. Choi,et al.  Clinical significance of pre‐S mutations in patients with genotype C hepatitis B virus infection , 2007, Journal of viral hepatitis.

[18]  G. Raimondo,et al.  Occult hepatitis B virus infection. , 2007, Journal of hepatology.

[19]  Ding‐Shinn Chen,et al.  High prevalence and mapping of pre-S deletion in hepatitis B virus carriers with progressive liver diseases. , 2006, Gastroenterology.

[20]  T. Poynard,et al.  Coexistence of Hepatitis B Surface Antigen (HBs Ag) and Anti-HBs Antibodies in Chronic Hepatitis B Virus Carriers: Influence of “a” Determinant Variants , 2006, Journal of Virology.

[21]  A. Chowdhury,et al.  Genotype, phylogenetic analysis, and transmission pattern of occult hepatitis B virus (HBV) infection in families of asymptomatic HBsAg carriers , 2006, Journal of medical virology.

[22]  C. Osiowy Detection of HBsAg mutants , 2006, Journal of medical virology.

[23]  B. Weber Diagnostic impact of the genetic variability of the hepatitis B virus surface antigen gene , 2006, Journal of medical virology.

[24]  G. Schochetman,et al.  HIV variants and hepatitis B surface antigen mutants: Diagnostic challenges for immunoassays , 2006, Journal of medical virology.

[25]  E. Tabor Infections by hepatitis B surface antigen gene mutants in Europe and North America , 2006, Journal of medical virology.

[26]  B. Weber Genetic variability of the S gene of hepatitis B virus: clinical and diagnostic impact. , 2005 .

[27]  R. Gehrke,et al.  Mutant hepatitis B virus surface antigens (HBsAg) are immunogenic but may have a changed specificity. , 2004, Virology.

[28]  P. Coursaget,et al.  Diagnostic Problems Caused by HBsAg Mutants – A Consensus Report of an Expert Meeting , 2004, Intervirology.

[29]  P. Coursaget,et al.  Genetic Diversity of Hepatitis B Virus Strains Derived Worldwide: Genotypes, Subgenotypes, and HBsAg Subtypes , 2004, Intervirology.

[30]  Y. Poovorawan,et al.  Mutation of the "a" determinant of HBsAg with discordant HBsAg diagnostic kits. , 2004, Viral immunology.

[31]  F. Zoulim,et al.  Cloning and expression of surface antigens from occult chronic hepatitis B virus infections and their recognition by commercial detection assays , 2004, Journal of medical virology.

[32]  J. Wands,et al.  Modulation of Hepatitis B Virus Secretion by Naturally Occurring Mutations in the S Gene , 2004, Journal of Virology.

[33]  P. Weinbreck,et al.  Serological pattern ‘anti-hepatitis B core alone’ in HIV or hepatitis C virus-infected patients is not fully explained by hepatitis B surface antigen mutants , 2004, AIDS.

[34]  J. Allain Occult hepatitis B virus infection. , 2004, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.

[35]  W. Gerlich Diagnostic problems caused by HBsAg mutants-a consensus report of an expert meeting. , 2004, Intervirology.

[36]  S. Levicnik-Stezinar Hepatitis B surface antigen escape mutant in a first time blood donor potentially missed by a routine screening assay. , 2004, Clinical laboratory.

[37]  H. Will,et al.  Deficiency in virion secretion and decreased stability of the hepatitis B virus immune escape mutant G145R , 2003, Hepatology.

[38]  M. Buti [Hepatitis B virus genotypes]. , 2003, Gastroenterologia y hepatologia.

[39]  K. Hu Occult hepatitis B virus infection and its clinical implications , 2002, Journal of viral hepatitis.

[40]  C. Osiowy Sensitive Detection of HBsAg Mutants by a Gap Ligase Chain Reaction Assay , 2002, Journal of Clinical Microbiology.

[41]  G. Lau,et al.  Prevalence of naturally occurring surface gene variants of hepatitis B virus in nonimmunized surface antigen–negative Chinese carriers , 2001, Hepatology.

[42]  C. Bréchot,et al.  Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: Clinically significant or purely “occult”? , 2001, Hepatology.

[43]  M. Shapiro,et al.  Licensed recombinant hepatitis B vaccines protect chimpanzees against infection with the prototype surface gene mutant of hepatitis B virus , 1999, Hepatology.

[44]  R. Prange,et al.  Role for Calnexin and N-Linked Glycosylation in the Assembly and Secretion of Hepatitis B Virus Middle Envelope Protein Particles , 1998, Journal of Virology.

[45]  A. Zuckerman,et al.  Vaccine-induced escape mutant of hepatitis B virus , 1990, The Lancet.